Viewing Study NCT02738008


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2025-12-26 @ 10:56 AM
Study NCT ID: NCT02738008
Status: TERMINATED
Last Update Posted: 2019-04-16
First Post: 2016-04-11
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
Sponsor: Arrowhead Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-03
Start Date Type: None
Primary Completion Date: 2016-12
Primary Completion Date Type: ACTUAL
Completion Date: 2016-12
Completion Date Type: ACTUAL
First Submit Date: 2016-04-11
First Submit QC Date: None
Study First Post Date: 2016-04-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-12-06
Results First Submit QC Date: None
Results First Post Date: 2019-04-16
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-01-11
Last Update Post Date: 2019-04-16
Last Update Post Date Type: ACTUAL